Bio-Rad Laboratories Financial Ratios
NYSE: BIOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bio-Rad Laboratories ratio analysis
Bio-Rad Laboratories earned a net margin of 29.4% in FY 2025, up from -71.9% a year earlier. Gross margin was 51.9% compared with a median of 55.0% over the prior 9 years. Return on equity reached 10.2%, meaning Bio-Rad Laboratories generated 0.10 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.16 versus 0.18 the year before, and the current ratio was 5.62. At the end of FY 2025, BIO traded at 11.0 times earnings; across the 7 fiscal years shown, its year-end P/E ranged from 4.6 to 207.1, with a median of 11.0. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Bio-Rad Laboratories financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 10.96 | — | — | — | 5.37 | 4.61 | 6.29 | 18.70 | 58.64 | 207.14 |
| Price / sales | 3.22 | 3.64 | 3.53 | 4.47 | 7.71 | 6.82 | 4.73 | 2.95 | 3.28 | 2.59 |
| Price / book | 1.12 | 1.42 | 1.08 | 1.30 | 1.65 | 1.75 | 1.90 | 1.68 | 2.42 | 2.08 |
| Gross margin | 51.9% | 53.7% | 53.4% | 55.9% | 56.1% | 56.5% | 54.4% | 53.4% | 55.0% | 55.0% |
| Operating margin | 1.8% | 10.5% | 12.6% | 17.2% | 17.1% | 16.6% | 9.9% | -4.5% | 5.5% | 2.7% |
| Net margin | 29.4% | -71.9% | -23.9% | -129.5% | 145.6% | 149.8% | 76.1% | 16.0% | 5.7% | 1.3% |
| Free cash flow margin | 14.5% | 11.3% | 8.2% | 2.9% | 18.3% | 18.7% | 15.5% | 6.8% | -0.3% | 3.6% |
| Return on equity (ROE) | 10.2% | -28.1% | -7.3% | -37.7% | 31.1% | 38.6% | 30.5% | 9.1% | 4.2% | 1.0% |
| Return on assets (ROA) | 7.2% | -19.7% | -5.2% | -26.9% | 23.9% | 29.4% | 22.0% | 6.5% | 2.9% | 0.7% |
| Debt / equity | 0.16 | 0.18 | 0.14 | 0.12 | 0.00 | 0.00 | 0.00 | 0.11 | 0.15 | 0.17 |
| Current ratio | 5.62 | 6.48 | 5.83 | 5.55 | 2.92 | 3.39 | 2.41 | 4.49 | 3.93 | 3.91 |
| Revenue growth | 0.7% | -3.9% | -4.7% | -4.1% | 14.8% | 10.1% | 1.0% | 6.0% | 4.4% | 2.4% |
| EPS growth | — | — | — | -186.5% | 11.4% | 117.0% | 381.6% | 197.3% | 362.5% | -76.3% |